Cryptorchidism: isolated and associated with other genitourinary defects

Area of Science:

• Pediatric Endocrinology
• Urology
• Developmental Biology

Background:

• Cryptorchidism is the most frequent disorder of sexual differentiation in male children.
• Its incidence is 3.4% in term newborns, decreasing to 0.8% by 1 year.
• Normal testicular descent involves the hypothalamic-pituitary-testicular axis, gubernaculum, and epididymis.

Purpose of the Study:

• To review the implications of cryptorchidism in male children.
• To discuss the long-term complications, including infertility and testicular cancer.
• To evaluate current treatment standards and recommendations.

Main Methods:

• Literature review of cryptorchidism mechanisms, complications, and treatments.
• Analysis of histological changes in undescended testes.
• Evaluation of clinical trial data for hormonal therapies.

Main Results:

• Testes show degenerative changes by 1-2 years of age, even with unilateral cryptorchidism.
• The risk of malignancy is 40 times higher in males with cryptorchidism.
• Orchiopexy (surgical correction) is the standard treatment, recommended between 12-18 months of age.

Conclusions:

• Early orchiopexy is crucial to prevent testicular degeneration and associated long-term risks.
• Hormonal therapy (HCG, LH-RH) lacks proven efficacy in US trials.
• Orchiopexy does not appear to reduce the risk of malignancy but is essential for managing cryptorchidism.